Covaxin Phase 3 Trial Protocol

Covaxin shows 77.8% efficacy in phase 3 trial data: All you need to know | Covid

Hindustan Times

‘Covaxin has 81% efficacy’: Bharat Biotech phase 3 trial results

Hindustan Times

Covaxin phase-3 trial will begin as second trial has successful results | India | Corona Vaccine

WION

Covaxin Shows 77% Efficacy In Phase 3 Trials, Bharat Biotech Informs Govt Panel, Data Under Review

Bharat Biotech's Covaxin Shows 77.8% Efficacy Rate In Phase 3 Trial

Bharat biotech submits phase 3 trial data, expert panel meet today| Covaxin | Oneindia News

Covaxin Phase 1 Trial Clears Lancet Review, Phase 3 Trial Ongoing

NDTV

Phase III Trials Of Bharat Biotech's Covaxin | CNBC-TV18

Covid-19 Vaccine: Covaxin Phase 3 Trial Data Shared With Expert Panel Which Meets Today

NDTV

Covaxin 77.8% Effective In Phase 3 Trial Data: Sources

NDTV

Covaxin Interim Results 'Encouraging', Phase 3 Trials To Continue: AIIMS Chief

NDTV

Bharat Biotech Covaxin phase III trial is approved by Subject Expert Committee with 77.8% efficacy

Covid-19 Vaccine: Bharat Biotech Releases Covaxin's Phase 3 Trial Data, Claims 77.8% Efficacy

NDTV

Bharat Biotech Phase 3 Results | Covaxin releases their interim analysis from phase three trials

‘Covaxin phase-3 trial probably largest clinical trial in India’: Principal Investigator

Covid update: Covaxin phase 3 trial; China locks down Hebei; UK vaccine supply

Hindustan Times

COVAXIN submits phase 3 trial results to World Health Organization for approval

Bharat Biotech Concludes Phase 3 trial Of Covaxin Records 77.8% Efficacy Rate

Covid update: Covaxin’s phase 3 trials; free vaccine promise; SII’s partnership

Hindustan Times

COVID Vaccine Updates: phase 3 trials of Bharat Biotech's 'Covaxin' begins in Bengaluru